Related references
Note: Only part of the references are listed.Higher Risk of Measles When the First Dose of a 2-Dose Schedule of Measles Vaccine Is Given at 12-14 Months Versus 15 Months of Age
Gaston De Serres et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Americas: Paving the Road Toward Global Measles Eradication
C. Carlos Castillo-Solorzano et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Laboratory Characterization of Measles Virus Infection in Previously Vaccinated and Unvaccinated Individuals
Carole J. Hickman et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Field Effectiveness of Live Attenuated Measles-Containing Vaccines: A Review of Published Literature
Amra Uzicanin et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS)
Christina Poethko-Mueller et al.
VACCINE (2011)
Long-Lasting Measles Outbreak Affecting Several Unrelated Networks of Unvaccinated Persons
Frederic Dallaire et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up
Irja Davidkin et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The effect of superspreading on epidemic outbreak size distributions
T. Garske et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns
E. Leuridan et al.
VACCINE (2007)
Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment
Charles W. LeBaron et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2007)
Measles elimination in Canada
A King et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age
M Paunio et al.
EPIDEMIOLOGY AND INFECTION (2000)
Share Paper
